ISMP warns of potential errors when emergency compounding Tamiflu

Formulary , 02/26/2013

Because Tamiflu has been in short supply recently, pharmacists and other healthcare providers are being warned about confusion over emergency compounding of the drug. Tamiflu’s manufacturer, Genentech, has Tamiflu 6 mg/mL oral suspension in 60 mL bottles on intermittent back order. The company is releasing product as it becomes available, but also provides instructions for compounding an extemporaneous 6 mg/mL oral suspension from 75–mg capsules, if required, according to The Institute for Safe Medication Practices (ISMP)

Read more: http://www.mdlinx.com/pharma-news/news-article.cfm/4442548/#ixzz2M6sPthlA